Strategy

strategy

Within strategy of development of pharmaceutical industry of the Russian Federation directed on decrease in dependence of domestic health care on import of medicines, JSC Binergia defined the following priorities of the activity:

  • Production of hi-tech preparations generics and innovative bioorganic medicines.
  • Development and production of active pharmaceutical substances.
  • Research, development and production of innovative medicines.
  • Conclusion to the market of modern and available medicines.
  • Control and maintenance of a high level quality at all stages from idea to production.

Besides, the company is focused on production of socially significant medicines. More than 60% in assortment of products make the preparations entering the List of vital and major medicines. These preparations are most significant both for patients and all health system in general.

We seek to provide the population of Russia safe, qualitative, effective and, the main thing, available medicine.